Major Objectives of the Study:
# To define, describe, and forecast the global Cell Isolation Market on the basis of product, cell type, cell source, technique, application, end user, and region.
# To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, and opportunities).
# To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall cell isolation market.
# To analyze the opportunities in the market for stakeholders and to provide details of the competitive landscape for market leaders.
# To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW).
# To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies.
# To track and analyze competitive developments such as product launches, partnerships, expansions, and acquisitions in the cell isolation market.
# To benchmark players within the market using proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product strategy.
Key Growth Driving Factors:
Market growth is driven by the the increasing number of patients suffering from cancer and infectious diseases, increasing government funding for cell-based research, the growing focus on personalized medicine and technological advancements.
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479
North America is the largest regional market for cell isolation market
The cell isolation market is segmented into four regions, namely, North America, Europe, Asia Pacific and Rest of the world. In 2019, North America accounted for the largest share of the cell isolation market. The large share of North America can be attributed to technological advancements, growth in the biotechnology and pharmaceutical industries, increasing prevalence of chronic and infectious diseases, and higher investments in cell-based research in the region.
Global Key Players:
The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Becton, Dickinson and Company Limited (US), Beckman Coulter Inc. (US).Merck KGaA (Germany), Terumo BCT (Japan), GE Healthcare (US), Bio- Rad Laboratories Inc. (US), Corning Inc. (US), Roche Diagnostics (Switzerland, Alfa Laval (Sweden), Miltenyl Biotech (Germany), pluriSelect Life Science (Germany), STEMCELL Technologies Inc. (Canada), Akadeum Life Sciences, Inc (US), Bio- Techne (US), Bio Legend (US) and Invent Biotechnologies (US).
Recent Developments:
# In May 2019, Thermo Fisher Scientific acquired Brammer Bio with the aim to expand capabilities to support the high growth gene and cell therapy market.
# In October 2018, Merck opened its M Lab Collaboration Center in São Paulo
# In May 2019, Beckman Coulter launched ClearLLab 10C System
End Users:
The biotechnology and biopharmaceutical companies segment accounted for the largest share in the market, by end user segment, in 2019
The cell isolation market is segmented into hospitals and diagnostic laboratories, biotechnology and biopharmaceutical companies, research laboratories and institutes, and other end users based on end users. In 2019, the biotechnology and biopharmaceutical companies segment accounted for the largest share. The widespread adoption of advanced instruments in cell-based experiments and cancer research in biotechnology and biopharmaceutical companies, as well as the increasing number of R&D facilities globally can be attributed for the the large share of this end-user segment.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=103931479
Projected Revenue Growth:
The global Cell Isolation market size is projected to reach USD 15.0 billion by 2025 from USD 6.9 billion in 2020, at a 16.8% CAGR.
